(Q57569726)
Statements
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology (English)
0 references
7 April 2006
0 references
17
0 references
7
0 references
1111-1119
0 references